{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T01:46:25Z","timestamp":1768873585663,"version":"3.49.0"},"reference-count":25,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Ethics"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1136\/medethics-2015-103282","type":"journal-article","created":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T02:45:35Z","timestamp":1480387535000},"page":"359-363","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Prescription preferences in antipsychotics and attitude towards the pharmaceutical industry in Belgium"],"prefix":"10.1136","volume":"43","author":[{"given":"Stijn","family":"Cleymans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Morrens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Bervoets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2016,11,28]]},"reference":[{"key":"key-10.1136\/medethics-2015-103282-1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.eurpsy.2014.09.417","article-title":"Pharmaceutical industry interactions of psychiatric trainees from 20 European countries","volume":"30","author":"Riese","year":"2015","journal-title":"Eur Psychiatry"},{"key":"key-10.1136\/medethics-2015-103282-2","doi-asserted-by":"crossref","first-page":"e1000352","DOI":"10.1371\/journal.pmed.1000352","article-title":"Information from pharmaceutical companies and the quality, quantity, and cost of physicians\u2019 prescribing: a systematic review","volume":"7","author":"Spurling","year":"2010","journal-title":"PLoS Med"},{"key":"key-10.1136\/medethics-2015-103282-3","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/jme.2005.014480","article-title":"Interactions of doctors with the pharmaceutical industry","volume":"32","author":"Morgan","year":"2006","journal-title":"J Med Ethics"},{"key":"key-10.1136\/medethics-2015-103282-4","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","article-title":"Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis","volume":"378","author":"Cipriani","year":"2011","journal-title":"Lancet"},{"key":"key-10.1136\/medethics-2015-103282-5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/PRA.0000000000000085","article-title":"Evolution of First-generation and Second-generation antipsychotic prescribing patterns in Belgium between 1997 and 2012: a population-based study","volume":"21","author":"Morrens","year":"2015","journal-title":"J Psychiatr Pract"},{"key":"key-10.1136\/medethics-2015-103282-6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/pds.2213","article-title":"National changes in oral antipsychotic treatment for people with schizophrenia in primary care between 1998 and 2007 in the United Kingdom","volume":"21","author":"Prah","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key-10.1136\/medethics-2015-103282-7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1176\/appi.ps.53.4.425","article-title":"Prescription of antipsychotic drugs by office-based physicians in the United States, 1989\u20131997","volume":"53","author":"Hermann","year":"2002","journal-title":"Psychiatr Serv"},{"key":"key-10.1136\/medethics-2015-103282-8","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N Engl J Med"},{"key":"key-10.1136\/medethics-2015-103282-9","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.63.10.1079","article-title":"Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)","volume":"63","author":"Jones","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"key-10.1136\/medethics-2015-103282-10","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1176\/appi.ps.201200186","article-title":"How quickly do physicians adopt new drugs? The case of second-generation antipsychotics","volume":"64","author":"Huskamp","year":"2013","journal-title":"Psychiatr Serv"},{"key":"key-10.1136\/medethics-2015-103282-11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.mp.4002136","article-title":"How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials","volume":"14","author":"Leucht","year":"2009","journal-title":"Mol Psychiatry"},{"key":"key-10.1136\/medethics-2015-103282-12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"key-10.1136\/medethics-2015-103282-13","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.biopsych.2004.01.027","article-title":"A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book","volume":"55","author":"Mishara","year":"2004","journal-title":"Biol Psychiatry"},{"key":"key-10.1136\/medethics-2015-103282-14","unstructured":"http:\/\/www.vvp-online.be (date accessed Oct 2015)."},{"key":"key-10.1136\/medethics-2015-103282-15","unstructured":"http:\/\/www.domusmedica.be\/documentatie\/nieuwskijker\/4841-weer-meer-huisartsen.html (date accessed Oct 2015)."},{"key":"key-10.1136\/medethics-2015-103282-16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-244X-12-27","article-title":"Choice of antipsychotic treatment by European psychiatry trainees: are decisions based on evidence?","volume":"12","author":"Jauhar","year":"2012","journal-title":"BMC Psychiatry"},{"key":"key-10.1136\/medethics-2015-103282-17","doi-asserted-by":"crossref","first-page":"e12193","DOI":"10.1371\/journal.pone.0012193","article-title":"Japanese practicing physicians\u2019 relationships with pharmaceutical representatives: a national survey","volume":"5","author":"Saito","year":"2010","journal-title":"PLoS ONE"},{"key":"key-10.1136\/medethics-2015-103282-18","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.ijrobp.2004.01.052","article-title":"A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers","volume":"59","author":"Halperin","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key-10.1136\/medethics-2015-103282-19","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/appi.ajp.161.7.1301","article-title":"Medical decision making in antipsychotic drug choice for schizophrenia","volume":"161","author":"Hamann","year":"2004","journal-title":"Am J Psychiatry"},{"key":"key-10.1136\/medethics-2015-103282-20","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/bmj.326.7400.1178","article-title":"Characteristics of general practitioners who frequently see drug industry representatives: national cross sectional study","volume":"326","author":"Watkins","year":"2003","journal-title":"BMJ"},{"key":"key-10.1136\/medethics-2015-103282-21","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4103\/0976-500X.114596","article-title":"Metabolic syndrome in schizophrenia: Differences between antipsychotic-na\u00efve and treated patients","volume":"4","author":"Chadda","year":"2013","journal-title":"J Pharmacol Pharmacother"},{"key":"key-10.1136\/medethics-2015-103282-22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/gerona\/glt101","article-title":"Metabolic syndrome and disability: findings from the prospective three-city study","volume":"69","author":"Carriere","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"key-10.1136\/medethics-2015-103282-23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.schres.2009.03.025","article-title":"Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study","volume":"111","author":"Patel","year":"2009","journal-title":"Schizophr Res"},{"key":"key-10.1136\/medethics-2015-103282-24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/met.2010.0105","article-title":"Metabolic syndrome components are associated with future medical costs independent of cardiovascular hospitalization and incident diabetes","volume":"9","author":"Nichols","year":"2011","journal-title":"Metab Syndr Relat Disord"},{"key":"key-10.1136\/medethics-2015-103282-25","unstructured":"JAMA instruction for authors. http:\/\/jama.jamanetwork.com\/public\/instructionsForAuthors.aspx (accessed 8 Sep 2016)."}],"container-title":["Journal of Medical Ethics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/medethics-2015-103282","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T19:32:38Z","timestamp":1601062358000},"score":1,"resource":{"primary":{"URL":"https:\/\/jme.bmj.com\/lookup\/doi\/10.1136\/medethics-2015-103282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,28]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,5,26]]},"published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.1136\/medethics-2015-103282"],"URL":"https:\/\/doi.org\/10.1136\/medethics-2015-103282","relation":{},"ISSN":["0306-6800","1473-4257"],"issn-type":[{"value":"0306-6800","type":"print"},{"value":"1473-4257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,28]]}}}